Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Little ones can do big things: Small molecule inhibitors target PTPN2/PTPN1 for tumor immunotherapy

Published:2024-05-29 Issue:6 Volume:5 Page:
ISSN:2688-2663
Container-title:MedComm
language:en
Short-container-title:MedComm

Author:

Wang Junyu¹,Qin Shugang²^ORCID,Zhang Anren¹

Affiliation:

1. Department of Rehabilitation Medicine Shanghai Fourth People's Hospital, School of Medicine, Tongji University Shanghai China

2. Department of Critical Care Medicine, Frontiers Science Center for Disease‐related Molecular Network State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University Chengdu China

Funder

National Natural Science Foundation of China

China Postdoctoral Science Foundation

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mco2.567

Reference5 articles.

1. The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity

2. PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells

3. In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target

4. Cancer immunotherapy using checkpoint blockade

5. A view on drug resistance in cancer

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP